Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:
Benefits:
/
Your filings are automatically published to your site as they are filed.
Investors don't have to leave your site to see filings.
Product Description
Once a report has been filed with the SEC it will be available on the website.
SEC Filings
Section 16 Filings Only
NOVADEL PHARMA INC filed this 8-K on 03/31/2010.
Click on link to view section or document
1. Entire Document including Exhibit(s)
2. 8-K
PAGE: 1 -
PAGE: 2 -
PAGE: 3 - SIGNATURES
3. EX-1.1 - Underwriting agreement
PAGE: 1 - Purchase Agreements
PAGE: 2 - SEC
PAGE: 3 - 1934 Act
PAGE: 4 - Consents
PAGE: 5 - Application of Takeover Protections; Rights Agreement
PAGE: 6 - Insolvent
PAGE: 7 - Foreign Corrupt Practices
PAGE: 8 - Certificate of Incorporation
PAGE: 9 - Contingent Obligation
PAGE: 10 - Title
PAGE: 11 - Internal Accounting and Disclosure Controls
PAGE: 12 - Registration Eligibility
PAGE: 13 - Management
PAGE: 14 - No Additional Agreements
PAGE: 15 - Indemnification
PAGE: 16 -
PAGE: 17 - Termination
PAGE: 18 - Closing
PAGE: 19 -
PAGE: 20 - Placement Agent Information and Relationship
PAGE: 21 - Signature page follows
PAGE: 22 -
4. EX-4.1 - Instruments defining the rights of security holders
PAGE: 1 - Transfer Agent
PAGE: 2 - Buy-In Price
PAGE: 3 - Disputes
PAGE: 4 - Required Reserve Amount
PAGE: 5 - New Issuance Price
PAGE: 6 -
PAGE: 7 - Number of Warrant Shares
PAGE: 8 - Variable Price Securities
PAGE: 9 - Distribution
PAGE: 10 - Corporate Event
PAGE: 11 - Redemption Right Event
PAGE: 12 - REISSUANCE OF WARRANTS
PAGE: 13 - NOTICES
PAGE: 14 - CONSTRUCTION; HEADINGS
PAGE: 15 - TRANSFER
PAGE: 16 - Black Scholes Consideration Value
PAGE: 17 - Closing Bid Price
PAGE: 18 - Convertible Securities
PAGE: 19 - Options
PAGE: 20 - signature page follows
PAGE: 21 - IN WITNESS WHEREOF,
PAGE: 22 - EXHIBIT A
PAGE: 23 -
PAGE: 24 - ACKNOWLEDGMENT
5. EX-4.2 - Instruments defining the rights of security holders
PAGE: 1 - Transfer Agent
PAGE: 2 - Buy-In Price
PAGE: 3 - Disputes
PAGE: 4 - Required Reserve Amount
PAGE: 5 - New Issuance Price
PAGE: 6 -
PAGE: 7 - Number of Warrant Shares
PAGE: 8 - Variable Price Securities
PAGE: 9 - Distribution
PAGE: 10 - Corporate Event
PAGE: 11 - Redemption Right Event
PAGE: 12 - REISSUANCE OF WARRANTS
PAGE: 13 - NOTICES
PAGE: 14 - CONSTRUCTION; HEADINGS
PAGE: 15 - TRANSFER
PAGE: 16 - Black Scholes Consideration Value
PAGE: 17 - Closing Bid Price
PAGE: 18 - Convertible Securities
PAGE: 19 - Options
PAGE: 20 - signature page follows
PAGE: 21 - IN WITNESS WHEREOF,
PAGE: 22 - EXHIBIT A
PAGE: 23 -
PAGE: 24 - ACKNOWLEDGMENT
6. EX-5.1 - Opinion regarding legality
PAGE: 1 -
7. EX-10.1 - Material contracts
PAGE: 1 - 1. PURCHASE AND SALE OF COMMON SHARES AND WARRANTS.
PAGE: 2 - Organization; Authority
PAGE: 3 - Subsidiary.
PAGE: 4 - 1934 Act
PAGE: 5 - Principal Market
PAGE: 6 - Dilutive Effect
PAGE: 7 - Insolvent
PAGE: 8 - Conduct of Business; Regulatory Permits
PAGE: 9 - Equity Capitalization
PAGE: 10 - Certificate of Incorporation
PAGE: 11 - Absence of Litigation
PAGE: 12 - Intellectual Property Rights
PAGE: 13 - Internal Accounting and Disclosure Controls
PAGE: 14 - Acknowledgement Regarding Buyers Trading Activity
PAGE: 15 - BHCA
PAGE: 16 - Money Laundering
PAGE: 17 - No Additional Agreements
PAGE: 18 - 10-K Filing
PAGE: 19 - Reporting Period
PAGE: 20 - Iroquois
PAGE: 21 - Additional Issuance of Securities
PAGE: 22 - Reservation of Shares
PAGE: 23 -
PAGE: 24 -
PAGE: 25 - Dilutive Issuances
PAGE: 26 - Corporate Existence
PAGE: 27 - Exhibit C
PAGE: 28 - Exhibit D
PAGE: 29 - 8. TERMINATION.
PAGE: 30 - Counterparts
PAGE: 31 - Notices
PAGE: 32 -
PAGE: 33 - Successors and Assigns
PAGE: 34 -
PAGE: 35 -
PAGE: 36 - U.S. Dollars
PAGE: 37 - signature pages follow
PAGE: 38 - IN WITNESS WHEREOF,
PAGE: 39 - IN WITNESS WHEREOF,
PAGE: 40 - IN WITNESS WHEREOF,
PAGE: 41 - IN WITNESS WHEREOF,
PAGE: 42 - IN WITNESS WHEREOF,
PAGE: 43 - SCHEDULE OF BUYERS
8. EX-10.2 - Material contracts
PAGE: 1 - Termination of Agreement
PAGE: 2 - Address for Notice:
9. EX-99.1 - Exhibits not specifically designated by another number and by investment companies
PAGE: 1 - FORWARD-LOOKING STATEMENTS:
Quote & Chart Package
Basic Stock Chart
Basic Stock Quote
Embedded Quote / Chart
Embedded Full Quote / Chart
Interactive Chart
Intraday Chart
Pop Up Quote
Scrolling Ticker
You are viewing our Quote and Chart Demo using ticker symbol
NVDL
T 800.650.1211
F 888.329.6696
E
info@stockgroup.com
© 2004 Stockgroup Media Inc.
Disclaimer